# A Study to Evaluate ENT-01 for the Treatment of Parkinson's Disease Dementia

> **NCT03938922** · PHASE1 · WITHDRAWN · sponsor: **Enterin Inc.**

## Conditions studied

- Parkinson Disease
- Dementia

## Interventions

- **DRUG:** Active Investigational Treatment ENT-01

## Key facts

- **NCT ID:** NCT03938922
- **Lead sponsor:** Enterin Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-03-01
- **Primary completion:** 2025-06-15
- **Final completion:** 2025-12-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Compound will not be studied for indication
- **Last updated:** 2024-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03938922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03938922, "A Study to Evaluate ENT-01 for the Treatment of Parkinson's Disease Dementia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03938922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*